Death causes in breast cancer patients. (Q48869594)

16 February 2018

title

Death causes in breast cancer patients. (English)

1 reference

16 February 2018

0 references

2

1 reference

16 February 2018

author name string

M Riihimäki

1

1 reference

16 February 2018

A Brandt

3

1 reference

16 February 2018

J Sundquist

4

1 reference

16 February 2018

K Hemminki

5

1 reference

16 February 2018

publication date

17 May 2011

1 reference

16 February 2018

published in

Annals of Oncology

1 reference

16 February 2018

volume

23

1 reference

16 February 2018

page(s)

604-610

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Misclassification of breast cancer as cause of death in a service screening area

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Competing causes of death for women with breast cancer and change over time from 1975 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Probabilities of death from breast cancer and other causes among female breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Breast cancer incidence and mortality trends in 16 European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Medical comorbidities predict mortality in women with a history of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Non-cancer mortality among people diagnosed with cancer (Australia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

The effect of comorbidity on 3-year survival of women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

A comparison of underlying cause and multiple causes of death: US vital statistics, 2000-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Diabetes mellitus and risk of breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

How is place of death from cancer changing and what affects it? Analysis of cancer registration and service data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Trousseau's syndrome: multiple definitions and multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

The hypercoagulable state of malignancy: pathogenesis and current debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Chemotherapy-induced thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Prevention of venous thromboembolism in the cancer surgical patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Hepatic complications of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Pathogenesis and management of postoperative ileus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Cardiovascular effects of breast cancer radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR160

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR160

1 reference

16 February 2018

PubMed ID

21586686

1 reference

16 February 2018